Predict your next investment

Aridhia Informatics company logo
INTERNET | Internet Software & Services / Healthcare
aridhia.com

See what CB Insights has to offer

Founded Year

2008

Stage

Grant - II | Alive

About Aridhia Informatics

Aridhia Informatics is focused in the management of chronic diseases, stratified medicine and biomedical research through the use of biomedical informatics and analytics. Aridhia believes that the integration and application of patient, clinical and genomic data represents a powerful opportunity to support clinical care across healthcare sectors, provide patients with the ability to take a more active role in their own care and provide information at a population level about disease trends, risk factors, impact of treatment and informed public health programs. Working in close collaboration with experts in a clinical faculty model, Aridhia's multidisciplinary team provides a unique combination of expertise to address one of the world's most pressing health problems.

Aridhia Informatics Headquarter Location

Hobart House 80 Hanover Street

Edinburgh, Scotland, EH2 1EL,

United Kingdom

+44 131 560 1470

Latest Aridhia Informatics News

Aridhia Informatics to manage data on new Alzheimer’s study

Aug 22, 2016

Aridhia Informatics to manage data on new Alzheimer’s study 13:54, 22 Aug 2016 The £6.9m Deep and Frequent Phenotyping study will be the most rigorous series of tests ever performed on volunteers to detect Alzheimer’s disease  Shares Get business news by email Software developer Aridhia Informatics has been selected to work on a new study which aims to improve detection of Alzheimer’s Dementia. The £6.9 million Deep and Frequent Phenotyping study will be the most rigorous series of tests ever performed on volunteers to detect Alzheimer’s disease. The study is being funded by the National Institute of Health Research (NIHR) and the Medical Research Council (MRC). Aridhia, a spin out from the University of Dundee, has developed a cloud-based data analysis platform to process and manage clinical and research informatics between organisations and across geographies. Aridhia will provide data analytics using its AnalytiXagility platform to help researchers analyse data gathered from 250 volunteers recruited from existing study cohorts led by the Dementias Platform UK. The Aridhia technology will also be made accessible to members of the multi-site team, which includes researchers at Edinburgh University, Oxford University and the Alzheimer’s Society. The study is designed to identify measureable characteristics, known as biomarkers, which can detect Alzheimer’s disease at an early stage, even when the person has displayed no obvious symptoms. The tests will include wearable devices which will provide researchers with detailed information on the wearer's movement and gait, and sophisticated retinal imaging to detect subtle changes affecting central and peripheral vision. Aridhia chief executive Chris Roche said: “Alzheimer’s dementia is a brutally progressive disease, for which we have no cure. “It is crucial that we gain a better understanding of the early stages, to help us discover which treatments can slow down or even stop the symptoms. “AnalytiXagility will help researchers to faster identify biomarkers, which will allow them to speed up the clinical trial process and find out which drugs are effective, and which ones are not. “This will ensure patients will benefit from the research more quickly, and also helps to streamline the process to make it more cost-effective.” TheScottishDailyRecord Previous Articles

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Aridhia Informatics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Aridhia Informatics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.